This evidence is supported by epigenome-wide studies (EWAS), which have assessed changes in the whole DNA methylation patterns from peripheral blood mononuclear cells (PBMCs) and CD4+ and CD8+ T cells in MS patients [84,85]. This evidence concerns the gene CD4 and myeloid sarcoma.